Sharma Meenakshi, Subramaniam Arulselvi, Sengar Kangana, Suri Vaishali, Agrawal Deepak, Chakraborty Nabarun, Pandey Ravindra Mohan, Malhotra Rajesh, Lalwani Sanjeev
Division of Forensic Pathology and Molecular DNA Laboratory, Jai Prakash Narayan Apex Trauma Centre, All India Institute of Medical Sciences, New Delhi, India.
Department of Laboratory Medicine, Jai Prakash Narayan Apex Trauma Centre, All India Institute of Medical Sciences, New Delhi, India.
J Lab Physicians. 2023 Feb 24;15(3):399-408. doi: 10.1055/s-0043-1761926. eCollection 2023 Sep.
Different deposition patterns and grading systems used to define and identify DAI remain discordant and to date these are a challenge in clinical practice. Our main objective was to study the post-mortem axonal changes and develop a grading system to identify DAI on the basis of histopathological and immunoreactive β-amyloid precursor protein (β-APP) observations in severe TBI cases. Prospective study with 35 decedents with sTBI (GCS score ≤ 8) was conducted and samples were collected from three different sites-corpus callosum, thalamus and brain stem. Serial sections from each site were stained with hematoxylin and eosin (H&E), and immunohistochemistry (IHC) of β-APP. We developed a grading system based on histopathological characteristics to assess the overall damage of axonal injury. We found maximum histopathological changes in cases with prolonged stay. Corpus callosum showed maximum changes in both gradings. Curiously, we also detected axonal swellings with H&E staining. Usually neglected, the thalamus also showed significant histopathological and immunoreactive changes for sTBI. Our study based on histopathological and β-APP scoring system to define and identify DAI thus facilitates accurate diagnosis of DAI post mortem, which has forensic implications, and may further contribute toward survival and improvement of quality of life of sTBI patients.
用于定义和识别弥漫性轴索损伤(DAI)的不同沉积模式和分级系统仍不一致,迄今为止,这些在临床实践中是一项挑战。我们的主要目标是研究死后轴突变化,并基于严重创伤性脑损伤(TBI)病例的组织病理学和免疫反应性β淀粉样前体蛋白(β-APP)观察结果开发一种分级系统,以识别DAI。
对35例重度TBI(格拉斯哥昏迷量表评分≤8)死者进行了前瞻性研究,并从胼胝体、丘脑和脑干三个不同部位采集样本。每个部位的连续切片用苏木精和伊红(H&E)染色,并进行β-APP免疫组织化学(IHC)检测。
我们基于组织病理学特征开发了一种分级系统,以评估轴突损伤的总体损伤情况。我们发现住院时间延长的病例组织病理学变化最大。胼胝体在两种分级中变化最大。奇怪的是,我们在H&E染色中也检测到了轴突肿胀。通常被忽视的丘脑在重度TBI中也显示出显著的组织病理学和免疫反应性变化。
我们基于组织病理学和β-APP评分系统来定义和识别DAI的研究,从而有助于死后DAI的准确诊断,这具有法医学意义,并且可能进一步有助于重度TBI患者的存活和生活质量的改善。